0001209191-24-001741.txt : 20240117
0001209191-24-001741.hdr.sgml : 20240117
20240117160525
ACCESSION NUMBER: 0001209191-24-001741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Semerjian Harout
CENTRAL INDEX KEY: 0001809747
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36177
FILM NUMBER: 24538442
MAIL ADDRESS:
STREET 1: 300 THE AMERICAN ROAD
STREET 2: C/O IMMUNOMEDICS, INC.
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLYCOMIMETICS INC
CENTRAL INDEX KEY: 0001253689
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-243-1201
MAIL ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-12
0
0001253689
GLYCOMIMETICS INC
GLYC
0001809747
Semerjian Harout
C/O GLYCOMIMETICS, INC
9708 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (right to buy)
3.11
2024-01-12
4
A
0
695000
0.00
A
2034-01-11
Common Stock
695000
695000
D
25% of the shares underlying this option will vest on January 12, 2025 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.
/s/ Brian F. Leaf, attorney-in-fact
2024-01-17